PAM
SBBP

Panagora Asset Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Panagora Asset Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,309
Closed -$7K – 2813
2021
Q2 		$7K Sell
2,309
-3,005
-57% -$7.93K ﹤0.01% 2410
2021
Q1 		$15K Sell
5,314
-5,409
-50% -$16.3K ﹤0.01% 2348
2020
Q4 		$26K Buy
10,723
+2,391
+29% +$5.76K ﹤0.01% 2160
2020
Q3 		$17K Sell
8,332
-22,725
-73% -$76.6K ﹤0.01% 2248
2020
Q2 		$117K Hold
31,057
– – ﹤0.01% 1736
2020
Q1 		$58K Sell
31,057
-2,304
-7% -$5.99K ﹤0.01% 1851
2019
Q4 		$69K Buy
33,361
+31,057
+1,348% +$59.5K ﹤0.01% 1873
2019
Q3 		$6K Buy
+2,304
New +$6.19K ﹤0.01% 2273
2018
Q3 		– Sell
-20,954
Closed -$126K – 2495
2018
Q2 		$126K Sell
20,954
-113,256
-84% -$829K ﹤0.01% 1785
2018
Q1 		$1.19M Buy
+134,210
New +$1M ﹤0.01% 1095
2017
Q3 		– Sell
-2,351
Closed -$17K – 2574
2017
Q2 		$17K Buy
+2,351
New +$10.9K ﹤0.01% 2316

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Panagora Asset Management's SBBP Position: Q3 2021 in Review

Panagora Asset Management sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2021, closing a stake of 2,309 shares — an estimated $7K sold.

Panagora Asset Management first reported a position in SBBP in Q2 2017 and held it in 11 quarters. The position peaked at $1.19M in Q1 2018. 49 funds tracked by Wall St. Rank hold SBBP as of Q3 2021.

  • Panagora Asset Management reported no remaining Strongbridge Biopharma plc. position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 2,309 Strongbridge Biopharma plc. shares in Q3 2021, an estimated $7K.
  • Panagora Asset Management first reported a position in Strongbridge Biopharma plc. in Q2 2017 and held it in 11 quarters.
  • Panagora Asset Management's Strongbridge Biopharma plc. position peaked at $1.19M in Q1 2018.
  • 49 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.